BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25211425)

  • 1. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin.
    Zhao Y; Wang S; Xia Q; Gamboa da Costa G; Doerge DR; Cai L; Fu PP
    Chem Res Toxicol; 2014 Oct; 27(10):1720-31. PubMed ID: 25211425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute configuration, stability, and interconversion of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine valine adducts and their phenylthiohydantoin derivatives.
    Jiang X; Wang S; Zhao Y; Xia Q; Cai L; Sun X; Fu PP
    J Food Drug Anal; 2015 Jun; 23(2):318-326. PubMed ID: 28911388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation.
    Zhao Y; Xia Q; Gamboa da Costa G; Yu H; Cai L; Fu PP
    Chem Res Toxicol; 2012 Sep; 25(9):1985-96. PubMed ID: 22857713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo.
    Fu PP; Chou MW; Churchwell M; Wang Y; Zhao Y; Xia Q; Gamboa da Costa G; Marques MM; Beland FA; Doerge DR
    Chem Res Toxicol; 2010 Mar; 23(3):637-52. PubMed ID: 20078085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
    Xia Q; He X; Ma L; Chen S; Fu PP
    Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity.
    Xia Q; Zhao Y; Von Tungeln LS; Doerge DR; Lin G; Cai L; Fu PP
    Chem Res Toxicol; 2013 Sep; 26(9):1384-96. PubMed ID: 23937665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glutathione and cysteine on pyrrolizidine alkaloid-induced hepatotoxicity and DNA adduct formation in rat primary hepatocytes.
    He X; Xia Q; Shi Q; Fu PP
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):109-123. PubMed ID: 32500832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
    He X; Xia Q; Ma L; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of pyrrolizidine alkaloids leading to phototoxicity and photogenotoxicity in human HaCaT keratinocytes.
    Wang CC; Xia Q; Li M; Wang S; Zhao Y; Tolleson WH; Yin JJ; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2014; 32(4):362-84. PubMed ID: 25436474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine.
    Xia Q; Chou MW; Edgar JA; Doerge DR; Fu PP
    Cancer Lett; 2006 Jan; 231(1):138-45. PubMed ID: 16356839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-glutathione pyrrole adduct: a potential DNA reactive metabolite of pyrrolizidine alkaloids.
    Xia Q; Ma L; He X; Cai L; Fu PP
    Chem Res Toxicol; 2015 Apr; 28(4):615-20. PubMed ID: 25768656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii hook.
    Xia Q; Chou MW; Lin G; Fu PP
    Chem Res Toxicol; 2004 May; 17(5):702-8. PubMed ID: 15144228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-N-Acetylcysteine-pyrrole conjugate-A potent DNA reactive metabolite of pyrrolizidine alkaloids.
    He X; Ma L; Xia Q; Fu PP
    J Food Drug Anal; 2016 Oct; 24(4):682-694. PubMed ID: 28911605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
    Wang YP; Yan J; Beger RD; Fu PP; Chou MW
    Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and secondary pyrrolic metabolites of pyrrolizidine alkaloids form DNA adducts in human A549 cells.
    He X; Xia Q; Wu Q; Tolleson WH; Lin G; Fu PP
    Toxicol In Vitro; 2019 Feb; 54():286-294. PubMed ID: 30366057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.